Enhancing microglia-dependent plaque clearance in the Alzheimer disease brain by targeting Ifi27l2a expression
Enhancing microglia-dependent plaque clearance in the Alzheimer disease brain by targeting Ifi27l2a expression
批准号:
10214069
负责人:
GAB SEOK KIM
金额:
$42.9万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-05-15 至 2023-10-31
关键词:
Abeta clearanceAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease pathologyAmyloidAmyloid beta-ProteinBlood VesselsBrainCell LineCerebral Amyloid AngiopathyDataDementiaDepositionDevelopmentDiagnosisDiseaseDown-RegulationEquilibriumExposure toFlow CytometryGene Expression ProfileGenesGenetic TranscriptionGliosisHumanImpairmentInflammatoryInterferon-alphaInterferonsIschemic StrokeLabelLatex BeadLightLiteratureMeasuresMediatingMessenger RNAMicroRNAsMicrogliaModelingMusNeurodegenerative DisordersNeuronsOntologyPathologicPathologyPathway interactionsPatientsPhagocytesPhagocytosisPhenotypePopulationProbabilityProcessProteinsRegulationRoleSamplingSenile PlaquesSmall Interfering RNAStimulusTestingTg2576Thalamic structureUp-Regulationabeta depositionage relatedagedbrain parenchymaeffectiveness testingin silicoin vivoknock-downmRNA Expressionmouse modelneuropathologynew therapeutic targetnovelnovel strategiesoverexpressionpredictive modelingpromoterprotein expressionresponsesingle cell analysissingle-cell RNA sequencingsmall hairpin RNAuptake
中文摘要
摘要
阿尔茨海默病(AD)和脑淀粉样血管病(CAA)是与衰老相关的破坏性疾病
涉及脑内淀粉样β蛋白(Aβ)病理性沉积的神经退行性疾病
软脑膜血管系统周围的薄壁组织。小胶质细胞(MG)摄取β显著
随着年龄的增长而减少,这可能导致淀粉样蛋白清除减少和斑块增加
积累。最近,一种新的MG亚群具有明显的基因表达特征(“疾病-
相关的小胶质细胞“;DAM)在AD患者吞噬Aβ的过程中起着关键作用。vbl.使用
单细胞RNA测序的无偏分析(ScRNAseq),我们发现干扰素-α-
诱导蛋白27样蛋白2a(Ifi27l2a)是MG中表达最高的基因,仅次于
缺血性卒中,随着年龄的增加而增加。利用这一发现作为起点,我们随后检查了
在AD和CAA条件下是否出现类似的上调。我们随后发现Ifi27l2a的mRNA
有症状的TgSwDI小鼠的大脑表达显著升高-这是一种
同时发展血管和实质Aβ沉积。在人类大脑样本中,我们发现
确诊为CAA和AD患者的MG切片中Ifi27l2a蛋白表达升高
病理对照和年龄匹配的非疾病对照。我们还在一名人类体内发现了Ifi27l2a的上调。
炎性刺激后的小胶质细胞系(HMC3)。我们对MG的scRNAseq分析
人群中ifi27l2a的表达与炎症基因和a
与吞噬(和DAM识别)基因呈负相关。鉴于我们关于以下方面的新发现
Ifi27l2a在MG/DAM表型中的作用以及已知的MG在β清除中的作用
Ifi27l2a在调节MG吞噬功能和β清除中的新作用
同时显示血管和实质淀粉样斑块形成的模型(TgSwDI)。
我们将测试我们的模型,在该模型中,MG患者Ifi27l2a表达增加促进吞噬能力下降
从而损害了Aβ的清除。在目标1中,我们将研究转录后的潜在机制。
如果是27l2a的规定。我们将使用原代MG(从老龄小鼠脑培养)和人MG细胞系
确定两个电子预测的microRNAs对Ifi27l2a水平的贡献及其结果
吞噬功能。在目标2中,我们将在体内演示Ifi27l2a在调节MG/DAM中的作用
吞噬细胞表型和确定Ifi27l2a下调促进增强的可能性
血管和实质Aβ斑块的清除。在这些研究中,我们将使用TgSwDI小鼠
Aβ期,血管沉积和实质斑块明显。如果成功,这些研究
将为增强Aβ聚集体在大脑中的清除提供新的方法基础。
英文摘要
Abstract
Alzheimer’s disease (AD) and cerebral amyloid angiopathy (CAA) are devastating aging-associated
neurodegenerative diseases which involve pathological deposition of amyloid-beta (Aβ) in the brain
parenchyma and around the leptomeningeal vasculature. Aβ uptake in microglia (MG) is strikingly
reduced with age, which may contribute to reduced amyloid clearance and increased plaque
accumulation. Recently, a novel subset of MG with a distinct gene expression signature (“disease-
associated microglia”; DAM) have emerged as a critical player in phagocytosis of Aβ in AD. Using
unbiased analysis of single-cell RNA sequencing (scRNAseq), we discovered that Interferon alpha-
inducible protein 27-like protein 2A (Ifi27l2a) is the most highly upregulated gene in MG following
ischemic stroke, with a greater increase in aging. Using this finding as a launch point, we then examined
if similar upregulation occurred in conditions of AD and CAA. We subsequently found that Ifi27l2a mRNA
expression is significantly elevated in the brain of symptomatic TgSwDI mice – a mouse model which
develops both vascular and parenchymal Aβ deposits. In human brain samples, we found significantly
elevated Ifi27l2a protein expression in MG in sections from patients with confirmed CAA and AD
pathology versus non-disease age-matched controls. We also found upregulation of Ifi27l2a in a human
microglial cell line (HMC3) following inflammatory challenge. Our scRNAseq analysis of the MG
population showed a positive correlation between Ifi27l2a expression and inflammatory genes and a
negative correlation with phagocytic (and DAM-identifying) genes. In light of our new findings regarding
the role of Ifi27l2a in MG/DAM phenotype and the known role of MG in Aβ clearance, we now propose
to explore the novel role of Ifi27l2a in regulating MG phagocytic function and Aβ clearance using a mouse
model which demonstrates both vascular and parenchymal amyloid plaque formation (TgSwDI).
We will test our model in which elevated Ifi27l2a expression in MG promotes reduced phagocytic capacity
and thus impaired clearance of Aβ. In aim 1, we will examine potential mechanisms of post-transcriptional
Ifi27l2a regulation. We will use primary MG (cultured from aged mouse brain) and a human MG cell line
to determine the contribution of two in silico predicted microRNAs on Ifi27l2a level and on resulting
phagocytic function. In aim 2, we will demonstrate the in vivo role of Ifi27l2a in regulating MG/DAM
phagocytic phenotype and determine the potential for Ifi27l2a down-regulation to promote enhanced
clearance of vascular and parenchymal Aβ plaques. For these studies, we will use TgSwDI mice at a
stage where Aβ vascular deposits and parenchymal plaques are evident. If successful, these studies
would provide the basis for new approaches for enhancing clearance of Aβ aggregates in the brain.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3390/ijms23168885
发表时间:
2022-08-10
期刊:
International journal of molecular sciences
影响因子:
5.6
作者:
[]
通讯作者:
Ifi27l2a as a therapeutic target for stroke
-
批准号:10719517
-
项目类别:
-
资助金额:$45.98万
-
财政年份:2023
-
负责人:GAB SEOK KIM
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: